Carmel Capital Partners LLC boosted its stake in Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 65.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 93,247 shares of the technology company's stock after purchasing an additional 36,790 shares during the period. Carmel Capital Partners LLC's holdings in Koninklijke Philips were worth $2,236,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Bessemer Group Inc. increased its holdings in Koninklijke Philips by 2,935.4% in the 1st quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company's stock valued at $51,000 after purchasing an additional 1,908 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in Koninklijke Philips by 1,170.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,439 shares of the technology company's stock valued at $62,000 after purchasing an additional 2,247 shares during the last quarter. Blue Trust Inc. increased its holdings in Koninklijke Philips by 30.0% in the 2nd quarter. Blue Trust Inc. now owns 4,408 shares of the technology company's stock valued at $106,000 after purchasing an additional 1,017 shares during the last quarter. Wealthquest Corp acquired a new stake in Koninklijke Philips in the 1st quarter valued at approximately $116,000. Finally, Allworth Financial LP increased its holdings in Koninklijke Philips by 16.2% in the 1st quarter. Allworth Financial LP now owns 4,638 shares of the technology company's stock valued at $115,000 after purchasing an additional 645 shares during the last quarter. Institutional investors and hedge funds own 13.67% of the company's stock.
Koninklijke Philips Price Performance
Koninklijke Philips stock opened at $28.54 on Friday. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69. The company has a fifty day simple moving average of $27.69 and a 200-day simple moving average of $25.35. The stock has a market cap of $27.48 billion, a P/E ratio of 150.18, a price-to-earnings-growth ratio of 0.76 and a beta of 0.82. Koninklijke Philips N.V. has a 12-month low of $21.48 and a 12-month high of $32.25.
Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.12. The firm had revenue of $5.05 billion during the quarter, compared to the consensus estimate of $4.35 billion. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. Equities analysts expect that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.
Analyst Ratings Changes
Several analysts recently weighed in on the stock. Weiss Ratings reiterated a "sell (d+)" rating on shares of Koninklijke Philips in a report on Wednesday, October 8th. Wall Street Zen downgraded shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy".
View Our Latest Stock Report on PHG
Koninklijke Philips Company Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
See Also
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips N.V. (NYSE:PHG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.